Michael B. Hoffman, Director at Annovis Bio, Inc. (ANVS), bought 76,344 shares at $1.75 ($143K) on 2026-05-20, disclosed to the SEC on 2026-05-21.
Open-market purchase of $143k ANVS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.75 | 2,562 | $4K | 3.1% |
| 2 | $1.80 | 18,849 | $34K | 23.8% |
| 3 | $1.90 | 54,933 | $104K | 73.1% |
| Total | $1.87 avg | 76,344 | $143K | 100% |
| Filing → |
| ANVS | BUY | 2025-11-25 | $276K | — | Filing → |
| ANVS | BUY | 2025-11-21 | $70K | — | Filing → |
| ANVS | BUY | 2025-11-18 | $32K | — | Filing → |